Annual Cash & Cash Equivalents
$89.07 M
+$5.28 M+6.30%
December 31, 2024
Summary
- As of March 13, 2025, PRLB annual cash & cash equivalents is $89.07 million, with the most recent change of +$5.28 million (+6.30%) on December 31, 2024.
- During the last 3 years, PRLB annual cash & cash equivalents has risen by +$23.14 million (+35.10%).
- PRLB annual cash & cash equivalents is now -30.20% below its all-time high of $127.60 million, reached on December 31, 2020.
Performance
PRLB Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$89.07 M
+$1.20 M+1.36%
December 31, 2024
Summary
- As of March 13, 2025, PRLB quarterly cash and cash equivalents is $89.07 million, with the most recent change of +$1.20 million (+1.36%) on December 31, 2024.
- Over the past year, PRLB quarterly cash and cash equivalents has increased by +$5.28 million (+6.30%).
- PRLB quarterly cash and cash equivalents is now -30.20% below its all-time high of $127.60 million, reached on December 31, 2020.
Performance
PRLB Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
PRLB Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +6.3% | +6.3% |
| 3 y3 years | +35.1% | +35.1% |
| 5 y5 years | -28.9% | -28.9% |
PRLB Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +57.5% | -7.4% | +62.9% |
| 5 y | 5-year | -30.2% | +57.5% | -30.2% | +112.5% |
| alltime | all time | -30.2% | +3195.3% | -30.2% | +1359.9% |
Proto Labs Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $89.07 M(+6.3%) | $89.07 M(+1.4%) |
| Sep 2024 | - | $87.87 M(-8.6%) |
| Jun 2024 | - | $96.15 M(+3.6%) |
| Mar 2024 | - | $92.80 M(+10.8%) |
| Dec 2023 | $83.79 M(+48.1%) | $83.79 M(+0.4%) |
| Sep 2023 | - | $83.50 M(+25.6%) |
| Jun 2023 | - | $66.49 M(+7.2%) |
| Mar 2023 | - | $62.05 M(+9.7%) |
| Dec 2022 | $56.56 M(-14.2%) | $56.56 M(-4.7%) |
| Sep 2022 | - | $59.36 M(+8.6%) |
| Jun 2022 | - | $54.67 M(-4.5%) |
| Mar 2022 | - | $57.24 M(-13.2%) |
| Dec 2021 | $65.93 M(-48.3%) | $65.93 M(+37.9%) |
| Sep 2021 | - | $47.80 M(+14.1%) |
| Jun 2021 | - | $41.91 M(-4.3%) |
| Mar 2021 | - | $43.77 M(-65.7%) |
| Dec 2020 | $127.60 M(+1.9%) | $127.60 M(+7.9%) |
| Sep 2020 | - | $118.25 M(+20.7%) |
| Jun 2020 | - | $98.00 M(+6.6%) |
| Mar 2020 | - | $91.91 M(-26.6%) |
| Dec 2019 | $125.22 M(+47.2%) | $125.22 M(+3.0%) |
| Sep 2019 | - | $121.57 M(+20.9%) |
| Jun 2019 | - | $100.53 M(+17.8%) |
| Mar 2019 | - | $85.35 M(+0.4%) |
| Dec 2018 | $85.05 M(+131.7%) | $85.05 M(+35.9%) |
| Sep 2018 | - | $62.59 M(-0.0%) |
| Jun 2018 | - | $62.60 M(+38.8%) |
| Mar 2018 | - | $45.09 M(+22.9%) |
| Dec 2017 | $36.71 M | $36.71 M(-69.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2017 | - | $119.28 M(+20.2%) |
| Jun 2017 | - | $99.20 M(+38.0%) |
| Mar 2017 | - | $71.89 M(+4.5%) |
| Dec 2016 | $68.80 M(+44.4%) | $68.80 M(+0.8%) |
| Sep 2016 | - | $68.22 M(+19.0%) |
| Jun 2016 | - | $57.33 M(+13.2%) |
| Mar 2016 | - | $50.63 M(+6.2%) |
| Dec 2015 | $47.65 M(+10.0%) | $47.65 M(-25.7%) |
| Sep 2015 | - | $64.13 M(+13.9%) |
| Jun 2015 | - | $56.32 M(+7.2%) |
| Mar 2015 | - | $52.55 M(+21.3%) |
| Dec 2014 | $43.33 M(+0.7%) | $43.33 M(+26.4%) |
| Sep 2014 | - | $34.27 M(+49.9%) |
| Jun 2014 | - | $22.85 M(-48.3%) |
| Mar 2014 | - | $44.20 M(+2.7%) |
| Dec 2013 | $43.04 M(+17.1%) | $43.04 M(+9.3%) |
| Sep 2013 | - | $39.38 M(+11.1%) |
| Jun 2013 | - | $35.45 M(+26.9%) |
| Mar 2013 | - | $27.93 M(-24.0%) |
| Dec 2012 | $36.76 M(+351.9%) | $36.76 M(+1.3%) |
| Sep 2012 | - | $36.29 M(-18.2%) |
| Jun 2012 | - | $44.39 M(-44.3%) |
| Mar 2012 | - | $79.68 M(+879.5%) |
| Dec 2011 | $8.13 M(+33.3%) | $8.13 M(-34.1%) |
| Sep 2011 | - | $12.35 M(+54.4%) |
| Jun 2011 | - | $8.00 M(-17.4%) |
| Mar 2011 | - | $9.69 M(+58.8%) |
| Dec 2010 | $6.10 M(+125.7%) | $6.10 M |
| Dec 2009 | $2.70 M | - |
FAQ
- What is Proto Labs annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Proto Labs?
- What is Proto Labs annual cash & cash equivalents year-on-year change?
- What is Proto Labs quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Proto Labs?
- What is Proto Labs quarterly cash and cash equivalents year-on-year change?
What is Proto Labs annual cash & cash equivalents?
The current annual cash & cash equivalents of PRLB is $89.07 M
What is the all time high annual cash & cash equivalents for Proto Labs?
Proto Labs all-time high annual cash & cash equivalents is $127.60 M
What is Proto Labs annual cash & cash equivalents year-on-year change?
Over the past year, PRLB annual cash & cash equivalents has changed by +$5.28 M (+6.30%)
What is Proto Labs quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of PRLB is $89.07 M
What is the all time high quarterly cash and cash equivalents for Proto Labs?
Proto Labs all-time high quarterly cash and cash equivalents is $127.60 M
What is Proto Labs quarterly cash and cash equivalents year-on-year change?
Over the past year, PRLB quarterly cash and cash equivalents has changed by +$5.28 M (+6.30%)